164221-12-9 Usage
Description
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol, commonly known as icosa-5,8,11,14,17-pentaen-1-ol, is a long-chain unsaturated alcohol with 20 carbon atoms and 5 double bonds arranged in a zig-zag configuration. It belongs to the family of long-chain unsaturated alcohols and possesses unique properties due to its multiple double bonds in the carbon chain.
Uses
Used in Industrial Applications:
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol is used as a raw material in the production of various industrial products, such as surfactants, lubricants, and plasticizers. Its unique properties make it suitable for various chemical and industrial processes.
Used in Pharmaceutical Industry:
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol has potential applications in the pharmaceutical industry, where it can be utilized for the development of new drugs or as an intermediate in the synthesis of pharmaceutical compounds.
Used in Cosmetic Industry:
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol can also be used in the cosmetic industry, where it may serve as an ingredient in the formulation of skincare products, hair care products, or other cosmetic formulations due to its unique properties.
Check Digit Verification of cas no
The CAS Registry Mumber 164221-12-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,4,2,2 and 1 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 164221-12:
(8*1)+(7*6)+(6*4)+(5*2)+(4*2)+(3*1)+(2*1)+(1*2)=99
99 % 10 = 9
So 164221-12-9 is a valid CAS Registry Number.
164221-12-9Relevant articles and documents
A New Lipobetaine from the Red Alga Neodilsea yendoana
Ishida, Ryoichi,Matsuo, Yoshihide,Suzuki, Minoru,Sato, Atsushi,Matsumoto, Takeshi
, p. 2427 - 2430 (1994)
A new isosanoid lipobetaine has been isolated from a red alga and its structure has been determined to be (2S)-2--(8Z,11Z,14Z)-8,11,14-icosatrienoylamino>-5-trimethylammoniopentanoate, mainly on the basis of NMR spectral and chemical means.
NSAID derivatives of omega-3 polyunsaturated acids as gamma secretase modulators
-
Page/Page column 14; 15, (2018/11/30)
The present invention relates to the NSAID derivatives of omega-3 fatty acids as gamma secretase modulators and their use in treating Alzheimer's disease, hypertriglyceridemia, and cardiovascular disease by reducing triglycerides, and for use as anti-inflammatory agents.
COMPOUND, COMPOSITION AND USES THEREOF
-
, (2017/05/10)
The compositions and compounds of formula I, formula II, formula III which includes a salt of polyunsaturated fatty acids in a molecular conjugate with amino acid isoleucine or its polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection administration. Such compositions may be used to treatment of hyperglycemia, metabolic syndrome, diabetes, pre-diabetes, lowering triglycerides or its associated complications.
